184 related articles for article (PubMed ID: 2049932)
1. C1 subcomponent complexes and C2 cleavage in active systemic lupus erythematosus.
Jonsson H; Sjöholm AG; Mårtensson U; Laurell AB; Sturfelt G
Complement Inflamm; 1991; 8(1):1-12. PubMed ID: 2049932
[TBL] [Abstract][Full Text] [Related]
2. C1 subcomponent complexes: basic and clinical aspects.
Laurell AB; Sjöholm AG
Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
[TBL] [Abstract][Full Text] [Related]
3. Sequential studies of complement activation in systemic lupus erythematosus.
Sturfelt G; Johnson U; Sjöholm AG
Scand J Rheumatol; 1985; 14(2):184-96. PubMed ID: 4001891
[TBL] [Abstract][Full Text] [Related]
4. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
Laurell AB; Mårtensson U; Sjöholm AG
J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
[TBL] [Abstract][Full Text] [Related]
5. Prospective analysis of C1 dissociation and complement activation in patients with systemic lupus erythematosus.
Jonsson H; Sturfelt G; Mårtensson U; Truedsson L; Sjöholm AG
Clin Exp Rheumatol; 1995; 13(5):573-80. PubMed ID: 8575134
[TBL] [Abstract][Full Text] [Related]
6. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
[TBL] [Abstract][Full Text] [Related]
7. Complement components, C1 activation and disease activity in SLE.
Sturfelt G; Sjöholm AG; Svensson B
Int Arch Allergy Appl Immunol; 1983; 70(1):12-8. PubMed ID: 6293980
[TBL] [Abstract][Full Text] [Related]
8. Trimer and tetramer complexes containing C1 esterase inhibitor, C1r and C1s, in serum and synovial fluid of patients with rheumatic disease.
Laurell AB; Mårtensson U; Sjöholm AG
J Immunol Methods; 1990 May; 129(1):55-61. PubMed ID: 2338498
[TBL] [Abstract][Full Text] [Related]
9. C1 activation and dissociation in disease.
Laurell AB; Mårtensson U; Sjöholm AG
Immunol Lett; 1987 Feb; 14(3):249-53. PubMed ID: 3032782
[TBL] [Abstract][Full Text] [Related]
10. Complement components, complement activation, and acute phase response in systemic lupus erythematosus.
Sturfelt G; Sjöholm AG
Int Arch Allergy Appl Immunol; 1984; 75(1):75-83. PubMed ID: 6086533
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies against Complement Classical Pathway Components C1q, C1r, C1s and C1-Inh in Patients with Lupus Nephritis.
Radanova M; Vasilev V; Mihaylova G; Kosturkova M; Kishore U; Roumenina L
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012546
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human complement subcomponent C1s lacking beta-hydroxyasparagine, sialic acid, and one of its two carbohydrate chains still reassembles with C1q and C1r to form a functional C1 complex.
Luo C; Thielens NM; Gagnon J; Gal P; Sarvari M; Tseng Y; Tosi M; Zavodszky P; Arlaud GJ; Schumaker VN
Biochemistry; 1992 May; 31(17):4254-62. PubMed ID: 1533159
[TBL] [Abstract][Full Text] [Related]
13. Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.
Thielens NM; Illy C; Bally IM; Arlaud GJ
Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):509-16. PubMed ID: 8042996
[TBL] [Abstract][Full Text] [Related]
14. Classical complement pathway components C1r and C1s: purification from human serum and in recombinant form and functional characterization.
Rossi V; Bally I; Lacroix M; Arlaud GJ; Thielens NM
Methods Mol Biol; 2014; 1100():43-60. PubMed ID: 24218249
[TBL] [Abstract][Full Text] [Related]
15. Complement activation, circulating C1q binding substances and inflammatory activity in rheumatoid arthritis: relations and changes on suppression of inflammation.
Berglund K; Laurell AB; Nived O; Sjoholm AG; Sturfelt G
J Clin Lab Immunol; 1980 Jul; 4(1):7-14. PubMed ID: 7463476
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of activation of the classical pathway of complement by Hageman factor fragment.
Ghebrehiwet B; Randazzo BP; Dunn JT; Silverberg M; Kaplan AP
J Clin Invest; 1983 May; 71(5):1450-6. PubMed ID: 6304147
[TBL] [Abstract][Full Text] [Related]
17. Surfactant protein A regulates complement activation.
Watford WT; Wright JR; Hester CG; Jiang H; Frank MM
J Immunol; 2001 Dec; 167(11):6593-600. PubMed ID: 11714829
[TBL] [Abstract][Full Text] [Related]
18. Circulating immune complexes and C1 activation in patients with rapidly progressive glomerulonephritis, before and after treatment with immunosuppression and plasma exchange.
Sjöholm AG; Brun C; Larsen S; Thysell H
Int Arch Allergy Appl Immunol; 1983; 72(1):9-15. PubMed ID: 6874103
[TBL] [Abstract][Full Text] [Related]
19. Activation of the first component of human complement (C1) by antibody-antigen aggregates.
Dodds AW; Sim RB; Porter RR; Kerr MA
Biochem J; 1978 Nov; 175(2):383-90. PubMed ID: 743203
[TBL] [Abstract][Full Text] [Related]
20. Structure of the C1r-C1s interaction of the C1 complex of complement activation.
Almitairi JOM; Venkatraman Girija U; Furze CM; Simpson-Gray X; Badakshi F; Marshall JE; Schwaeble WJ; Mitchell DA; Moody PCE; Wallis R
Proc Natl Acad Sci U S A; 2018 Jan; 115(4):768-773. PubMed ID: 29311313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]